REBIF - 44087-0022-3 - (INTERFERON BETA-1A)

Alphabetical Index


Drug Information of REBIF

Product NDC: 44087-0022
Proprietary Name: REBIF
Non Proprietary Name: INTERFERON BETA-1A
Active Ingredient(s): 22    ug/.5mL & nbsp;   INTERFERON BETA-1A
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of REBIF

Product NDC: 44087-0022
Labeler Name: EMD Serono, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103780
Marketing Category: BLA
Start Marketing Date: 20020307

Package Information of REBIF

Package NDC: 44087-0022-3
Package Description: 12 SYRINGE, GLASS in 1 CARTON (44087-0022-3) > .5 mL in 1 SYRINGE, GLASS

NDC Information of REBIF

NDC Code 44087-0022-3
Proprietary Name REBIF
Package Description 12 SYRINGE, GLASS in 1 CARTON (44087-0022-3) > .5 mL in 1 SYRINGE, GLASS
Product NDC 44087-0022
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name INTERFERON BETA-1A
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20020307
Marketing Category Name BLA
Labeler Name EMD Serono, Inc.
Substance Name INTERFERON BETA-1A
Strength Number 22
Strength Unit ug/.5mL
Pharmaceutical Classes Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient]

Complete Information of REBIF


General Information